| Dr Charles F Bou-abboud, MD | |
|
58 Brookshire Lane, Beckley, WV 25801-6765 | |
| (304) 252-4900 | |
| (304) 252-8470 |
| Full Name | Dr Charles F Bou-abboud |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 34 Years |
| Location | 58 Brookshire Lane, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255324844 | NPI | - | NPPES |
| 6001170000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 16314 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Raleigh General Hospital | Beckley, WV | Hospital |
| Beckley Arh Hospital | Beckley, WV | Hospital |
| Entity Name | Charles F Bou-abboud Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801137104 PECOS PAC ID: 8224275961 Enrollment ID: O20130516000384 |
News Archive
Urovalve, a medical device company focused on creating superior products for urinary flow and control, announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the Company's Surinate® Bladder Management System, allowing Urovalve to conduct a clinical study for the Company's lead device in the United States.
Abnormal binocular vision, which involves the way eyes work together as a team, increases dramatically as we age, according to research from the University of Waterloo. The study also found a correlation between this condition, general health and antidepressant use.
Two major non-commercial health information technology organizations are working together in a new vendor-neutral health IT innovation network designed to stimulate development of new ideas and shorten the time required to bring new solutions into practice.
While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk.
4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that initial safety and efficacy data from its ongoing Phase II Study with resminostat, a pan-Histone Deacetylase (HDAC) Inhibitor, in relapsed/refractory Hodgkin Lymphoma (HL) patients after high dose chemotherapy and autologous hematopoietic stem cell transplantation will be presented at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, USA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles F Bou-abboud, MD 58 Brookshire Lane, Beckley, WV 25801-6765 Ph: (304) 252-4900 | Dr Charles F Bou-abboud, MD 58 Brookshire Lane, Beckley, WV 25801-6765 Ph: (304) 252-4900 |
News Archive
Urovalve, a medical device company focused on creating superior products for urinary flow and control, announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the Company's Surinate® Bladder Management System, allowing Urovalve to conduct a clinical study for the Company's lead device in the United States.
Abnormal binocular vision, which involves the way eyes work together as a team, increases dramatically as we age, according to research from the University of Waterloo. The study also found a correlation between this condition, general health and antidepressant use.
Two major non-commercial health information technology organizations are working together in a new vendor-neutral health IT innovation network designed to stimulate development of new ideas and shorten the time required to bring new solutions into practice.
While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk.
4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that initial safety and efficacy data from its ongoing Phase II Study with resminostat, a pan-Histone Deacetylase (HDAC) Inhibitor, in relapsed/refractory Hodgkin Lymphoma (HL) patients after high dose chemotherapy and autologous hematopoietic stem cell transplantation will be presented at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, USA.
› Verified 6 days ago
Divya S. Rajan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1832 Harper Rd, Beckley, WV 25801 Phone: 681-207-7129 Fax: 681-207-7132 | |
Dr. Luis Alejandro Asencio Magdaleno, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1717 Harper Rd, Second Floor, Suite G, Beckley, WV 25801 Phone: 304-461-3922 | |
Dr. Seema Anand, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 | |
Thair A Barghouthi, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 304 Carriage Dr, Beckley, WV 25801 Phone: 304-254-0892 Fax: 304-254-0893 | |
Dr. Hafiz Imran Iqbal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 242 George St, Beckley, WV 25801 Phone: 304-255-7878 Fax: 304-256-0060 | |
Norma J Mullins, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3771 Robert C Byrd Drive, Beckley, WV 25801 Phone: 304-255-5710 Fax: 304-255-5702 | |
Jose Jorge Gordinho, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2962 Robert C. Byrd Drive, Beckley, WV 25801 Phone: 304-254-9022 Fax: 304-254-9024 |